%0 Journal Article
%T Multidisciplinary approach of liver metastases from colorectal cancer
%A Yuki Kitano
%J Archive of "Annals of Gastroenterological Surgery".
%D 2019
%R 10.1002/ags3.12227
%X Colorectal cancer liver metastases (CRLM) represent most of the causes of death in patients with colorectal cancer. Surgical resection is the only treatment that can provide the possibility of prolonged survival, or even cure, for patients with CRLM. Over the last few decades, survival of these patients has improved dramatically thanks to more effective chemotherapy, extension of surgical indications, and development of new surgical procedures. In particular, patients with initially unresectable CRLM can achieve downsizing of the tumor by using various chemotherapies and the tumor can become resectable. It has been shown that such patients have a 33% 5©\year survival and a 23% 10©\year survival rate after surgery, which is a little bit lower than that of patents with resectable CRLM but significantly higher than patients without surgery. However, a decision©\making strategy for patients with CRLM is difficult because there is a wide variety of treatments and no definitive consensus. As an example, much variation among institutions exists on the resectability rate in patients with unresectable CRLM. Also, it is recommended that all patients with CRLM be managed by a multidisciplinary approach (MDA) to select the best strategy. In the future, new treatment procedures (e.g. immune checkpoint blockade, liver transplantation) may contribute to improve prognosis; hence, the necessity for MDA for the treatment of CRLM will further increase
%K colorectal cancer liver metastases
%K multidisciplinary approach
%K OncoSurge approach
%K unresectable colorectal cancer liver metastases
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345652/